Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing.

While none passed multiple testing correction, mainly because of a lack of power since we have a limited sample size in an analysis with thousands of parameters (clones), we could observe that the few clones that approached significance ( P -value < 0.05) were shared across patients only in PR group and enriched at 24 months post transplant.

also in 8,237 other papers

NP) and showed a trend of a higher number of persistent clones ( P -value [linear regression] = 0.09).

also in 53,322 other papers